(Q45143202)

10 December 2017

title

Structural and functional in silico analysis of LRRK2 missense substitutions (English)

1 reference

10 December 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Jordi Pérez-Tur

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Marta Tormos-Pérez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

1 reference

2 February 2014

1 reference

Molecular Biology Reports

10 December 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

2529-2542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json

Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

LRRK2 and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

LRRK2 in Parkinson's disease: protein domains and functional insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Ancient origin of the Parkinson disease gene LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Structure of the Roc–COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Parkinson's disease: from monogenic forms to genetic susceptibility factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

LRRK2 in Parkinson's disease: function in cells and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

EasyModeller: A graphical interface to MODELLER

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Phylogenetic and in silico structural analysis of the Parkinson disease-related kinase PINK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Prediction of protein stability changes for single-site mutations using support vector machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Eris: an automated estimator of protein stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Sequence feature-based prediction of protein stability changes upon amino acid substitutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Human non-synonymous SNPs: server and survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

PMUT: a web-based tool for the annotation of pathological mutations on proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Regulate axon branching by the cyclic GMP pathway via inhibition of glycogen synthase kinase 3 in dorsal root ganglion sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

GSK3 alpha and GSK3 beta are necessary for axon formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Leucine-rich repeat kinase 2 mutants I2020T and G2019S exhibit altered kinase inhibitor sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Regulation of protein kinases; controlling activity through activation segment conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Identification of ALK as a major familial neuroblastoma predisposition gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

The function of semaphorins during nervous system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Identification of the autophosphorylation sites of LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Kinetic, mechanistic, and structural modeling studies of truncated wild-type leucine-rich repeat kinase 2 and the G2019S mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

LRRK2 in Parkinson's disease: genetic and clinical studies from patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3111-Z

Genetic contributions to Parkinson's disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24488318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Amino acid substitutions in the human genome: evolutionary implications of single nucleotide polymorphisms.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24488318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11033-014-3111-Z

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 June 2020

1021691849

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488318%20AND%20SRC:MED&resulttype=core&format=json